Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Strides Delivers Strong Performance with FY26 EBITDA at ₹9,253m, Operational PAT at ₹5,181m, 50% YoY Growth".
Press Release May 18 2026
Filed with NSE · · 3 pages · English
Release
Strides Pharma Science Ltd on 6ix
In the deck
Earlier from Strides Pharma Science
- Press Release Mar 17 2026
- Press Release (Revised) Feb 05 2026
- Press Release Feb 05 2026
- Press Release Jan 30 2026
- Press Release Oct 31 2025
Later from Strides Pharma Science
- Strides Pharma Science Ltd Press Release Jun 27 2026
- Strides Pharma Science Ltd Press Release Jul 31 2026
- Strides Pharma Science Ltd Press Release Aug 19 2026
- Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time".
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science